scholarly journals Absent 99mTc-MIBI Uptake in the Thyroid Gland during Early Phase of Parathyroid Scintigraphy in Patients with Primary and Secondary Hyperparathyroidism

2018 ◽  
Vol 6 (5) ◽  
pp. 808-813 ◽  
Author(s):  
Anamarija Jovanovska ◽  
Bojana Stoilovska ◽  
Magdalena Mileva ◽  
Daniela Miladinova ◽  
Venjamin Majstorov ◽  
...  

BACKGROUND: Thyroid uptake of technetium-99m methoxyisobutylisonitrile (99mTc-MIBI) during parathyroid scintigraphy can be affected by various conditions.AIM: To evaluate the frequency of absent 99mTc-MIBI uptake by the thyroid gland in the early phase of dual-phase parathyroid scintigraphy.METHODS: The early planar images of dual phase Tc99m MIBI parathyroid scintigraphy from 217 patients performed between 2014 and 2017 were retrospectively analysed. Patients were divided into two groups. The first group included 147 patients with primary hyperparathyroidism and the second group included 70 patients with chronic renal failure. Patient records, laboratory and ultrasonographic data were analysed in all patients. Descriptive statistic was used for data analysis.RESULTS: Out of all patients in the first group, 18 patients (12.24%) showed absent thyroid uptake. Thyroidectomy was performed in 44.4% of these patients, and the rest of them had some thyroid disease. Only one patient had no thyroid or another chronic disease. In the second group, 8 patients (11.42%) presented with absent thyroid uptake of MIBI. Among them, 5 patients had no history of thyroid disease and had been on hemodialysis programme, and 3 patients had hypothyroidism.CONCLUSION: Absent 99mTc-MIBI uptake in the thyroid during the early phase of parathyroid scintigraphy is most frequently related to thyroid disease. A small proportion of patients with chronic renal failure can present with absent 99mTc-MIBI uptake in the thyroid as well. The mechanism for this alteration is still unclear and needs further investigation.

1995 ◽  
Vol 34 (03) ◽  
pp. 100-103 ◽  
Author(s):  
U. Schrell ◽  
M. Buchfelder ◽  
J. Hensen ◽  
J. Wendler ◽  
M. Gramatzki ◽  
...  

SummaryNeuroendocrine tumors with somatostatin receptor expression may be localized by 111ln-octreotide scintigraphy. This study examines those thyroid conditions where 111 ln-octreotide uptake could be observed also in the thyroid gland. 26 consecutive patients who underwent 111 ln-octreotide scintigraphy for tumor localization were additionally examined for thyroid disease by sonography and 99mTc-pertechnetate scintigraphy. 12 of these patients had no significant thyroid uptake and had an euthyroid normal-sized thyroid gland. 14 patiens with 111ln thyroid uptakes had endemic goiters, two of them with thyroid autonomy and one with Graves’ disease. Thus, 111 ln-octreotide thyroid uptake was predominantly seen in patients with endemic goiter with or without thyroid autonomy.


2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
Amir Bashkin ◽  
Wagde Abu Saleh ◽  
Ohad Ronen

Abstract Introduction: Subclinical hypothyroidism is common in chronic diseases such as heart failure and advanced chronic renal failure. It is unclear whether this is a thyroid disease or an isolated TSH elevation. The goal of this study was to investigate the prevalence of worsening thyroid function in these patients with recurrent admissions. Methods: We performed a retrospective review of medical records of hospitalized patients in non-surgical wards from 2013–2016. First, all patients with TSH levels above the normal range (4.95 mIU/L) and up to 12 mIU/L with FT4 levels in the normal range were identified. We then investigated which of these patients were re-hospitalized at least once within at least six months. According to data from the re-hospitalization, an increase in TSH level above 12 mIU/L or initiation of levothyroxine treatment was defined as worsening of thyroid function. Patients treated with a drug affecting thyroid function or with a known thyroid disease prior to first hospitalization were excluded from the study. Chronic heart failure and chronic renal failure were determined according to reported diagnosis and drug treatment. Chronic renal failure patients were included if the glomerular filtration rate (GFR) in the first hospitalization was below 30 ml/min/1.72 square meter. Results: Overall, 90,199 TSH tests were sent from the non-surgical wards, most of them as part of the admissions profile. Of these, 2,116 hospitalizations met the inclusion criteria of the first hospitalization. In the final analysis, 126 inpatients with at least one re-hospitalization were included, of whom 43 (34.1%) had chronic heart failure and 22 (17.5%) had chronic renal failure. According to the most recent re-hospitalization, thyroid function was worse in 11(8.7%), 4 (9.3%) and 2 (9.1%) patients of the total, heart failure and renal failure groups respectively. The TSH level was found to be normal in re-hospitalization in 81.4% of those with heart failure and 86.4% of those with renal-failure. No association between heart failure or renal-failure and thyroid function worsening was found (p = 1.00 for both). Of 34 patients with chronic heart failure re-hospitalized after 1/2-1 year, in 29 (85.3%) the repeated TSH was normal, in 3 (8.8%) it was unchanged and in 2 (5.9%) it was worse. In most re-hospitalization the worsening was due to initiation of Levothyroxin treatment and because of the retrospective nature of the study we cannot be sure whether the initiation was justified; therefore, it is likely that the worsening percentage is even lower. Conclusions: An isolated TSH elevation in hospitalized patients with past medical history of chronic heart-failure or chronic renal failure does not indicate thyroid disease, in most cases.


1970 ◽  
Vol 7 (1) ◽  
pp. 10-14
Author(s):  
Roksana Yeasmin ◽  
Md Nizamul Hoque Bhuiyan ◽  
Sultana Parveen ◽  
Shamim Ara Ferdous ◽  
Nazmun Nahar

A case control study was done during the period of July 2004 to 2005. The study was carried out in the Department of Biochemistry, Dhaka Medical College, Dhaka. 50 diagnosed chronic renal failure patients of both sexes not yet treated by dialysis and 50 age and sex matched healthy subjects were included in the study as case (Group-II) and control (Group-I) respectively. In this study, mean serum HS CRP concentration of CRF patients (50.938 ±38.88)mg/l found to be significantly elevated in comparison to control (1.12±.29mg/l). In CRF patients, serum HS CRP found to show a strong negative correlation with creatinine clearance and a strong positive correlation with blood urea, serum creatinine. This study shows an inverse linear relationship between HS CRP and CCRin contrast to the inverse curvilinear relationship found to exist between serum creatinine and creatinine clearance. Regression analysis between CCR and HS CRP shows a rise of HS CRP Y one unit (mg/l) is accompanied by creatinine clearance to be decreased by 0 .44ml/min. Mean serum HS CRP concentration in chronic renal failure increases significantly. Early phase of decreased CCR can not be detected by the serum creatinine because serum creatinine does not increase until there is significant fall ( 30 ml/min) of creatinine clearance. In contrast to this serum HS CRP begins to rise from the very beginning of the fall of creatinine clearance. So the early phase of decreased creatinine clearance could be detected by simultaneous rise of serum HS CRP. Key Words: HS CRP, CRF, CCR.     DOI = 10.3329/jom.v7i1.1356 J MEDICINE 2006; 7 : 10-14


1995 ◽  
Vol 28 (2) ◽  
pp. 159-164 ◽  
Author(s):  
Rie Miura ◽  
Shigeru Yumita ◽  
Emi Yahagi ◽  
Yoko Hongo ◽  
Junko Matsuki ◽  
...  

Nephron ◽  
1985 ◽  
Vol 40 (2) ◽  
pp. 171-174 ◽  
Author(s):  
Laszlo Hegedüs ◽  
Jesper R. Andersen ◽  
Lars R. Poulsen ◽  
Hans Perrild ◽  
Birger Holm ◽  
...  

Nephrology ◽  
2018 ◽  
Vol 24 (1) ◽  
pp. 127-133
Author(s):  
Xiao Xiao ◽  
Yan Liu ◽  
Xiaoshi Zhong ◽  
Yun Liu ◽  
Daoyuan Zhou ◽  
...  

2003 ◽  
Vol 131 (1-2) ◽  
pp. 10-16 ◽  
Author(s):  
Danica Bukvic ◽  
Ljubica Djukanovic ◽  
Slavenka Jankovic

Up to now, detailed investigation of tubular function in patients with endemic nephropathy have been performed in the relatively small number of patients who have already been in chronic renal failure /3,4,5,9,15/. That is why we started this work with the aim to determine renal function of the patients suffering by endemic nephropathy in different stages of the disease, especially in the early stage of the disease. The study included 119 patients with endemic nephropathy who were grouped according to creatinine clearance values into four groups (Table 1). The first group covered the patients with normal crearinine clearance values, and other three covered the patients who were in the different stages of renal failure. The diagnosis of endemic nephropathy was established according to criteria given by Danilovic /7/ and Velimirovic /8/ after ruling out the known renal diseases. The results of clinical and laboratory examinations were processed by appropriate epidemiological and statistical techniques. The results proved that there was no significant difference between sexes of our patients (p>0,05). Objective examination reveals characteristic tan pale yellow with copperish glow on the cheeks, in 15,48% of our patients in the early stage of the disease, which is in accordance with the results of Velimirovic/8/. Among nephropathy patients 13% of them had kidney smaller than normal measured by sonography, and even 51% measured by static scintigraphy, in the early phase of the disease (Table 4, Table 5). The earlier works /11,12/ mainly supported that kidneys get smaller during renal insufficiency, and in the early phase of the disease kidneys have a normal size, whereas the later works indicated that even the patients with normal glomerular filtration have smaller kidneys/13,14,15,16/. The laboratory findings and urine analysis of this disease suggested absens of biochemical indicators of inflammation in endemic nephropathy patients (Table 2, Table 3), which is in accordance with the previous in investigations. We noticed correlation between ceatinine clearance values and values of serum beta 2 microglobulin (r==,56; p==,0002; Figure 1). It has been documented that with decreased of creatinine clearance values serum values of beta 2 microglobulin increased, in chronic renal failure /22/. Quantitative measuring of proteinuria shows values less than 1,0g/l in all examined patients. Proteinuria of tubular type has been described in endemic nephropathy/5,8,13,16/. Beta 2 microglobulinuria have been registered at 10,97% patients with normal creatinine clearance values (Table 7). Increased urinry contrecation of beta 2 microglobulin is generally accepted as an important feature of endemic nephropathy /19,20,21/. Glicosuria increased with the progression of the disease. Urine osmolallity of endemic nephropathy patients decreased with the progression of chronic renal failure (Table 6). 65,46% of the investigated patients of the first group, who were in the clinically early phase of the disease, had decreased urine osmolallity (measuring by coefficient of osmolallity U osm/Posm). The tubular reabsorbtion of the phosphate decreased with the progression of chronic renal failure and that correlation was statistically significant r<0,69; p<0,05; Figure 2). Fractional tubular excretion of sodium increased with the progression of endemic nephropathy (Table7). The obteined results of the function of proximal tubul are comparabile with the results of the other authors, but in the smaller number of patients /4,13,15,16/. Our results of functional investigations of kidney et patients with endemic nephropathy suggests primary tubular dysfunction, and reduced kidney size and that was registered in the early phase of the disease.


Sign in / Sign up

Export Citation Format

Share Document